Precision Medicine in the Prostate Cancer Care Pathway

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 14, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions
Prostate CancerGenetic Predisposition
Interventions
GENETIC

Prostate cancer risk gene panel

A list of genes created by study experts, thought to increase the risk of prostate cancer from from review previous research, this list is regularly reviewed for accuracy

Trial Locations (1)

SM2 5PT

RECRUITING

Royal Marsden Hosital,, Sutton

All Listed Sponsors
collaborator

Royal Marsden NHS Foundation Trust

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER